HBM Healthcare Investments AG

Key Figures 31.03.2024

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million

Key Figures 15.03.2024

Key Figures 29.02.2024

Key Figures 15.02.2024

Key Figures 31.01.2024

HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year

Key Figures 15.01.2024

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023

Key Figures 31.12.2023

Key Figures 15.12.2023

Key Figures 30.11.2023

AbbVie to acquire HBM portfolio company ImmunoGen for USD 10.1 billion in cash

Key Figures 15.11.2023

Key Figures 31.10.2023

Key Figures 15.10.2023

HBM Healthcare Investments activates share buyback programme

HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year

Key Figures 30.09.2023

HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 237.22 as at 30 September 2023

Key Figures 15.09.2023

Key Figures 31.08.2023

Key Figures 15.08.2023

Key Figures 31.07.2023

HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year

Key Figures 15.07.2023

Key Figures 30.06.2023

Cathay Biotech raises capital and enters into major strategic collaboration with China Merchants Group

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

Key Figures 15.06.2023